podcast banner image

Listen in each week to stay up to date on the most recent medication therapy topics. GameChangers creates awareness about pharmacotherapy and clinical practice changes that can significantly impact pharmacy practice. 

Episodes are accredited for CPE for Pharmacists through CEimpact.

Subscribe to our Weekly Subscription Service to
earn CE for the podcasts!

GameChangers |  CEImpact
Evidence for SGLT2 Drugs for Heart Failure in Patients without Diabetes | GameChangers
Pharmacy Podcast Network

Geoff Wall, PharmD & Jamie Pitlick, PharmD discussing SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption of glucose in the kidney and therefore lower blood sugar.  Recently SGLTs, which are currently indicated for Type 2 diabetes, have been investigated and received FDA approval for Heart failure with reduced ejection fraction (HFrEF).  Listen in to this episode to discover more about how these drugs work in this (HFrEF) disease state.

This episode is accredited for CPE.  This episode is accredited for CPE.  For CE details and to claim credit click here:  https://bit.ly/2ApMvWw 

See omnystudio.com/policies/listener for privacy information.


Proud to be a partner with Pharmacy Podcast Network